Author:
Roberto Natalia,Portella Maria J.,Marquié Marta,Alegret Montserrat,Hernández Isabel,Mauleón Ana,Rosende-Roca Maitee,Abdelnour Carla,de Antonio Ester Esteban,Gil Silvia,Tartari Juan P.,Vargas Liliana,Espinosa Ana,Ortega Gemma,Pérez-Cordón Alba,Sanabria Ángela,Orellana Adelina,de Rojas Itziar,Moreno-Grau Sonia,Montrreal Laura,Alarcón-Martín Emilio,Ruíz Agustín,Tárraga Lluís,Boada Mercè,Valero Sergi
Abstract
AbstractNeuropsychiatric symptoms (NPS) have been recently addressed as risk factors of conversion to Alzheimer’s disease (AD) and other dementia types in patients diagnosed with Mild Cognitive Impairment (MCI). Our aim was to determine profiles based on the prominent NPS in MCI patients and to explore the predictive value of these profiles on conversion to specific types of dementia. A total of 2137 MCI patients monitored in a memory clinic were included in the study. Four NPS profiles emerged (classes), which were defined by preeminent symptoms: Irritability, Apathy, Anxiety/Depression and Asymptomatic. Irritability and Apathy were predictors of conversion to dementia (HR = 1.43 and 1.56, respectively). Anxiety/depression class showed no risk effect of conversion when compared to Asymptomatic class. Irritability class appeared as the most discriminant neuropsychiatric condition to identify non-AD converters (i.e., frontotemporal dementia, vascular dementia, Parkinson’s disease and dementia with Lewy Bodies). The findings revealed that consistent subgroups of MCI patients could be identified among comorbid basal NPS. The preeminent NPS showed to behave differentially on conversion to dementia, beyond AD. Therefore, NPS should be used as early diagnosis facilitators, and should also guide clinicians to detect patients with different illness trajectories in the progression of MCI.
Funder
Ministerio de Ciencia e Innovación of the Spanish Government and Instituto de Salud Carlos III
Centro de Investigación Biomédica en Red de Salud Mental
ERDF and CERCA Programme / Generalitat de Catalunya
European Union’s Horizon 2020 research and innovation programme
CIBERNED (Instituto de Salud Carlos III
EU/EFPIA Innovative Medicines Initiative Joint Undertaking
ADAPTED
EXIT project funded by EU Euronanomed3 Program JCT2017
Acción Estratégica en Salud- Spanish National RCDCI Plan - Instituto de Salud Carlos III (ISCIII)- Subdirección General de Evaluación and the Fondo Europeo de Desarrollo Regional
Fundación bancaria “La Caixa”
Grífols SA
Publisher
Springer Science and Business Media LLC
Cited by
45 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献